|
|
News Breaks | | | | February 27, 2013 | | 09:25 EDT |  | HUM | Humana to reaffirm FY13 EPS view $7.60-$7.80, consensus $7.93
Members of Humana’s senior management team are scheduled to meet with investors at various times between February 28 and March 31. During such meetings, Humana’s management expects to reaffirm its FY13 EPS guidance and to address the preliminary 2014 Medicare Advantage benchmark payment rates released by the Centers for Medicare and Medicaid Services on February 15. The company believes the preliminary base rates included in the CMS Notice would result in a mid-single-digit decline in its benchmark payment rates. The company expects that the preliminary base rates included in the CMS notice would cause significant disruption for Medicare beneficiaries served by Humana in the form of market exits, decreases in benefits and/or increases in premiums, and/or reductions in services provided as a result of operating cost structure optimization. The company is conducting a market-by-market assessment that will be refined further once final rates are known in order to determine necessary actions and implications on margins, membership and overall earnings. | |
|
News For HUM From The Last 14 Days Check below for free stories on HUM the last two weeks. |
|
|
| June 17, 2013 | | 06:42 EDT |  | HUM | Choices provided by health insurance exchanges to vary widely, NY Times says
 Subscribe for More Information | |
|
|
|
|
|
|
